Review article · 2026 · Open access
GLP-1 Receptor Agonists in Periodontology: Mechanisms, Clinical Evidence, and Implications for Care
Biomolecules, 16(6), 857 · Published 11 June 2026 · DOI 10.3390/biom16060857
In brief
“GLP-1 Receptor Agonists in Periodontology: Mechanisms, Clinical Evidence, and Implications for Care” is a 2026 review article by Irina-Georgeta Șufaru and 10 co-authors, published in Biomolecules. OpenAlex counts 6 citations as of 18 November 2026, which puts it in the top 3% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Biomolecules.
- Citations
- 6
- Most cited in
- 2026 (6)
- Field-weighted impact
- 3.56
- References
- 166
- Authors
- 11
Abstract
GLP-1 receptor agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes and obesity and are increasingly relevant in periodontal and implant practice. This review covers mechanisms, preclinical and early human evidence, and practical periodontal considerations; the structured database search is conducted in accordance with the Scale for the Assessment of Narrative Review Articles (SANRA) and the International Committee of Medical Journal Editors (ICMJE) principles. Two pathways explain GLP-1RAs' relevance: indirect effects from better glycemic control, weight loss, and reduced inflammation; and direct tissue effects involving GLP-1R signaling and the GLP-1/dipeptidyl peptidase-4 (DPP-4) axis. Preclinical studies show reduced inflammation, osteoclast activity, and alveolar bone loss, along with improved periodontal stem cell function under hyperglycemia or inflammation via Nuclear Factor-kappaB (NF-kappaB), Wingless-related integration site (Wnt)/beta-catenin, and Mitogen-Activated Protein Kinase (MAPK) pathways. Animal studies on implants and local delivery, including exendin-4 platforms, suggest osteometabolic benefits. Human data are limited and mostly observational, and confounders include metabolic status, smoking, medication, and nutrition. Oral side effects such as xerostomia and dehydration are also noted. At present, GLP-1RA therapy should be regarded as a contextual modifier of periodontal risk and healing capacity rather than as a stand-alone periodontal therapy.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Șufaru, I.-G., Vasiliu, B. C., Hăncianu, M., Stratul, Ş., Tatarciuc, M., Iovan, G., Tatarciuc, D., Rudnic, I., Hanu, D., Paduraru, S., & Solomon, S. M. (2026). GLP-1 Receptor Agonists in Periodontology: Mechanisms, Clinical Evidence, and Implications for Care. Biomolecules, 16(6), 857. https://doi.org/10.3390/biom16060857
MLA 9
Șufaru, Irina-Georgeta, et al. “GLP-1 Receptor Agonists in Periodontology: Mechanisms, Clinical Evidence, and Implications for Care.” Biomolecules, vol. 16, no. 6, 2026, p. 857. https://doi.org/10.3390/biom16060857.
Chicago
Șufaru, Irina-Georgeta, Bogdan Constantin Vasiliu, Monica Hăncianu, Ştefan‐Ioan Stratul, Monica Tatarciuc, Gianina Iovan, Diana Tatarciuc, et al. 2026. “GLP-1 Receptor Agonists in Periodontology: Mechanisms, Clinical Evidence, and Implications for Care.” Biomolecules 16 (6): 857. https://doi.org/10.3390/biom16060857.
Harvard
Șufaru, I.-G. et al. (2026) ‘GLP-1 Receptor Agonists in Periodontology: Mechanisms, Clinical Evidence, and Implications for Care’, Biomolecules, 16(6), p. 857. doi:10.3390/biom16060857.
IEEE
I.-G. Șufaru et al., “GLP-1 Receptor Agonists in Periodontology: Mechanisms, Clinical Evidence, and Implications for Care,” Biomolecules, vol. 16, no. 6, p. 857, 2026, doi: 10.3390/biom16060857.
BibTeX
@article{sufaru2026receptor,
title = {{GLP-1 Receptor Agonists in Periodontology: Mechanisms, Clinical Evidence, and Implications for Care}},
author = {Șufaru, Irina-Georgeta and Vasiliu, Bogdan Constantin and Hăncianu, Monica and Stratul, Ştefan‐Ioan and Tatarciuc, Monica and Iovan, Gianina and Tatarciuc, Diana and Rudnic, Ioana and Hanu, Diana and Paduraru, Sorina and Solomon, Sorina Mihaela},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {6},
pages = {857},
doi = {10.3390/biom16060857},
url = {https://doi.org/10.3390/biom16060857}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- GLP-1 receptor agonists
- periodontal disease
- exendin-4
- dipeptidyl peptidase IV
- glycemic control
- weight loss
- periodontal inflammation
- alveolar bone loss
Work with this paper
Most-cited papers in Dentistry
- Periodontal Disease in Pregnancy II. Correlation Between Oral Hygiene and Periodontal ConditionJohn Silness, Harald A. Löe · Acta Odontologica Scandinavica · 1964 · 8,071 citations
- Periodontal Disease in Pregnancy I. Prevalence and SeverityHarald A. Löe, John Silness · Acta Odontologica Scandinavica · 1963 · 7,339 citations
- Microbial complexes in subgingival plaqueS. S. Socransky, Anne D. Haffajee, MaryAnn Cugini and 2 more · Journal Of Clinical Periodontology · 1998 · 5,207 citations
- Development of a Classification System for Periodontal Diseases and ConditionsGary C. Armitage · Annals of Periodontology · 1999 · 5,198 citations
- Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†ERIC L. SCHIFFMAN, Richard K. Ohrbach, Edmond L. Truelove and 27 more · Journal of Oral & Facial Pain and Headache · 2014 · 4,942 citations
Questions about this paper
How do I cite this paper in APA style?
Șufaru, I.-G., Vasiliu, B. C., Hăncianu, M., Stratul, Ş., Tatarciuc, M., Iovan, G., Tatarciuc, D., Rudnic, I., Hanu, D., Paduraru, S., & Solomon, S. M. (2026). GLP-1 Receptor Agonists in Periodontology: Mechanisms, Clinical Evidence, and Implications for Care. Biomolecules, 16(6), 857. https://doi.org/10.3390/biom16060857
How many times has this paper been cited?
6 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Biomolecules: sign in and open the PDF from this page.
Who wrote this paper?
Irina-Georgeta Șufaru, Bogdan Constantin Vasiliu, Monica Hăncianu, Ştefan‐Ioan Stratul, Monica Tatarciuc, Gianina Iovan, Diana Tatarciuc, Ioana Rudnic, Diana Hanu, Sorina Paduraru, Sorina Mihaela Solomon.
What is the DOI of this paper?
10.3390/biom16060857, permanently at https://doi.org/10.3390/biom16060857. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.